CVE-2025-4647

A user with elevated privileges can bypass sanitization measures by replacing the content of an existing SVG

Description

Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Centreon web allows Reflected XSS. A user with elevated privileges can bypass sanitization measures by replacing the content of an existing SVG. This issue affects web: from 24.10.0 before 24.10.5, from 24.04.0 before 24.04.11, from 23.10.0 before 23.10.22, from 23.04.0 before 23.04.27, from 22.10.0 before 22.10.29.

Category

8.4
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.03%
Vendor Advisory centreon.com
Affected: Centreon web
Published at:
Updated at:

References

Link Tags
https://thewatch.centreon.com/latest-security-bulletins-64/cve-2024-55574-centreon-web-high-severity-4435 vendor advisory
https://github.com/centreon/centreon/releases release notes

Frequently Asked Questions

What is the severity of CVE-2025-4647?
CVE-2025-4647 has been scored as a high severity vulnerability.
How to fix CVE-2025-4647?
To fix CVE-2025-4647, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-4647 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-4647 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-4647?
CVE-2025-4647 affects Centreon web.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.